Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nassim Kamar

Showing results (1-10 of 629) with videos related to

Pageof 63
Sort By:
Hepatitis Monthly|February 7, 2012
Hepatitis e virus infection in Iranian kidney-transplant patientsNassim Kamar
Transplantation|April 24, 2008
Negative impact of one-year anemia on long-term patient and graft survival in kidney transplant patients receiving calcineurin inhibitors and mycophenolate mofetilNassim Kamar, Lionel Rostaing
Nephrologie & Therapeutique|February 11, 2026
Management of cytomegalovirus in kidney transplantation in light of the new international recommendationsIlies Benotmane, Nassim Kamar
Hepatology (Baltimore, Md.)|February 7, 2019
No Clear Evidence for an Effect of Sofosbuvir Against Hepatitis E Virus in Organ Transplant PatientsNassim Kamar, Qiuwei Pan
Kidney International|February 4, 2014
Can we prevent donor-specific antibodies from developing after ABO-incompatible kidney transplantation?Lionel Rostaing, Nassim Kamar
Journal of Nephrology|February 16, 2010
mTOR inhibitor/proliferation signal inhibitors: entering or leaving the field?Lionel Rostaing, Nassim Kamar
Cold Spring Harbor Perspectives in Medicine|May 9, 2018
Acute and Persistent Hepatitis E Virus Genotype 3 and 4 Infection: Clinical Features, Pathogenesis, and TreatmentNassim Kamar, Sven Pischke
Medecine Sciences : M/S|January 1, 2009
[Hepatitis E: from zoonotic transmission to chronic infection in immunosuppressed patients]Jacques Izopet, Nassim Kamar
Transplantation|July 9, 2009
Is a single low-fixed dose of rituximab sufficient for treating acute humoral rejection after kidney transplantation?Nassim Kamar, Lionel Rostaing
Hepatology (Baltimore, Md.)|November 12, 2013
Does chronic hepatitis E virus infection exist in immunocompetent patients?Nassim Kamar, Jacques Izopet
Pageof 63

Showing results (1-10 of 629) with videos related to

Sort By:
Pageof 63
Hepatitis Monthly|February 7, 2012
Hepatitis e virus infection in Iranian kidney-transplant patientsNassim Kamar
Transplantation|April 24, 2008
Negative impact of one-year anemia on long-term patient and graft survival in kidney transplant patients receiving calcineurin inhibitors and mycophenolate mofetilNassim Kamar, Lionel Rostaing
Nephrologie & Therapeutique|February 11, 2026
Management of cytomegalovirus in kidney transplantation in light of the new international recommendationsIlies Benotmane, Nassim Kamar
Hepatology (Baltimore, Md.)|February 7, 2019
No Clear Evidence for an Effect of Sofosbuvir Against Hepatitis E Virus in Organ Transplant PatientsNassim Kamar, Qiuwei Pan
Kidney International|February 4, 2014
Can we prevent donor-specific antibodies from developing after ABO-incompatible kidney transplantation?Lionel Rostaing, Nassim Kamar
Journal of Nephrology|February 16, 2010
mTOR inhibitor/proliferation signal inhibitors: entering or leaving the field?Lionel Rostaing, Nassim Kamar
Cold Spring Harbor Perspectives in Medicine|May 9, 2018
Acute and Persistent Hepatitis E Virus Genotype 3 and 4 Infection: Clinical Features, Pathogenesis, and TreatmentNassim Kamar, Sven Pischke
Medecine Sciences : M/S|January 1, 2009
[Hepatitis E: from zoonotic transmission to chronic infection in immunosuppressed patients]Jacques Izopet, Nassim Kamar
Transplantation|July 9, 2009
Is a single low-fixed dose of rituximab sufficient for treating acute humoral rejection after kidney transplantation?Nassim Kamar, Lionel Rostaing
Hepatology (Baltimore, Md.)|November 12, 2013
Does chronic hepatitis E virus infection exist in immunocompetent patients?Nassim Kamar, Jacques Izopet
Pageof 63